Welcome to Heartopia, your home away from home! Building and customizing your new humble abode is all part of the fun. To start off, your Heartopia house will only have three housing plots. Home Plots ...

Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). She has been writing for Game Rant since ...

The Federal Reserve still sees just one rate cut in 2026, unchanged from its last forecast about three months ago. The central bank's so-called dot plot, which anonymously shows 19 individual members' ...

The literary landscape of the 21st century seems more and more divided when it comes to one particular aspect: plot. Some books have it; others don’t. The have-nots have gotten a lot of critical ...

An expanded version of the Jimi Hendrix Experience's second album is at the center of an upcoming box set. The four-CD Bold as Love includes remastered versions of the group's second album, 1967's ...

Labels, particularly when applied to human beings and their behavior, can have a surprisingly polarizing effect, regardless of the label’s efficacy. Some people resist labels altogether, while others ...

Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. Investopedia / Photo ...

It’s a family affair this time around, with Ben Mankiewicz examining all that went into the making of the scandalous epic directed by his uncle Joe. By Mike Barnes Senior Editor As TCM notes, the ...

Nothing amplifies a popular trend more than a prominent critic making a noisy case against it. In her 2021 polemic, “The Case Against the Trauma Plot,” the literary critic Parul Sehgal argued that ...

In recent advancements in life sciences, optical microscopy has played a crucial role in acquiring high-quality three-dimensional structural and functional information. However, the quality of 3D ...

PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood disorder after reviewing encouraging results from a phase 3 study. In the ...